References
- Guidance for Management of Pregnant Women in COVID-19 Pandemic. Mumbai, India: ICMR - National Institute for Research in Reproductive Health, 2020 Apr 12. Available from:
https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women in_COVID19_Pandemic_12042020.pdf - World Health Organization. Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period. Updated 15 March 2022. Q&A. Available from:
https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-pregnancy-and-childbirth - Kucirka LM, Norton A, Sheffield JS. Severity of COVID-19 in pregnancy: A review of current evidence. Am J Reprod Immunol. 2020;84(5):e13332. doi: 10.1111/aji.13332
- Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–7. doi: 10.1016/j.ajog.2003.11.019
- Azinheira Nobrega Cruz N, Stoll D, Casarini DE, Bertagnolli M. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility. Clin Sci (Lond). 2021;135(15):1805–24. doi: 10.1042/CS20210284
- Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–80.e8. doi: 10.1016/j.cell.2020.02.052
- Valdés G, Neves LA, Anton L, Corthorn J, Chacón C, Germain AM, et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006;27(2–3):200–7. doi: 10.1016/j.placenta.2005.02.015
- Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al.; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320; Update in: BMJ. 2022 May 30;377:o1205
- Centre for Disease Control and Prevention. COVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. 2021. Available from:
https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html or CDC Centre for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States. Last updated July 20, 2022. Available from:https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html - Januszewski M, Ziuzia-Januszewska L, Jakimiuk AA, Wierzba W, Gluszko A, Zytynska-Daniluk J, et al. Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study. Int J Environ Res Public Health. 2021;18(22):12011. doi: 10.3390/ijerph182212011
- Balachandren N, Davies MC, Hall JA, Stephenson JM, David AL, Barrett G, et al. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Hum Reprod. 2022;37(6):1126–33. doi: 10.1093/humrep/deac062
- Sivanandan S, Chawla D, Kumar P; National Neonatology Forum of India (NNF), Federation of Obstetric and Gynaecological Societies of India (FOGSI), and Indian Academy of Pediatrics (IAP). Update to Perinatal-Neonatal Management of COVID-19 Guidelines. Indian Pediatr. 2022;59(1):63–6. doi: 10.1007/s13312-022-2423-7
- Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY, et al.; CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med. 2021;385(16):1533–5. doi: 10.1056/NEJMc2113891
- Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al.; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021 Jun 17;384(24):2273–82. doi: 10.1056/NEJMoa2104983. Erratum in: N Engl J Med. 2021 Oct 14;385(16):1536
- World Health Organization. Coronavirus disease (COVID-19): Vaccines. Q&A. Last updated 17 May 2022. Available from:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines - Rottenstreich M, Sela HY, Rotem R, Kadish E, Wiener-Well Y, Grisaru-Granovsky S. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG. 2022;129(2):248–55. doi: 10.1111/1471-0528.16941
- Peretz-Machluf R, Hirsh-Yechezkel G, Zaslavsky-Paltiel I, Farhi A, Avisar N, Lerner-Geva L, et al. Obstetric and Neonatal Outcomes following COVID-19 Vaccination in Pregnancy. J Clin Med. 2022;11(9):2540. doi: 10.3390/jcm11092540
- Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine. 2020 Aug;25:100446. doi: 10.1016/j.eclinm.2020.100446
- Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641–7. doi: 10.15585/mmwr.mm6944e3
- Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540–E548. doi: 10.1503/cmaj.202604
- Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27(10):1693–5. doi: 10.1038/s41591-021-01490-8
- Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. 2021;326(8):728–35. doi: 10.1001/jama.2021.11035
- Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225(3):303.e1–303.e17. doi: 10.1016/j.ajog.2021.03.023
- Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, et al. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol. 2022;226(2):236.e1–236.e14. doi: 10.1016/j.ajog.2021.08.007
- Peepal P, Rath TS, Nayak S, Pendyala S. Maternal and neonatal outcomes among women with and without severe acute respiratory syndrome corona virus-2 infection: A retrospective analytical study. J Mother Child. 2021;25(2):77–85. doi: 10.34763/jmotherandchild.20212502.d-21-00021
- Karasek D, Baer RJ, McLemore MR, Bell AJ, Blebu BE, Casey JA, et al. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. Lancet Reg Health Am. 2021 Oct;2:100027. doi: 10.1016/j.lana.2021.100027
- Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, et al. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(1):26–30. doi: 10.15585/mmwr.mm7101e1
- Dick A, Rosenbloom JI, Gutman-Ido E, Lessans N, Cahen-Peretz A, Chill HH. Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study. BMC Pregnancy Childbirth. 2022;22(1):166. doi: 10.1186/s12884-022-04505-5
- Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. N Engl J Med. 2021;385(21):2008–2010. doi: 10.1056/NEJMc2114466
- Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, et al. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021. Vaccine. 2022;40(24):3389–94. doi: 10.1016/j.vaccine.2022.04.031
- Yang YJ, Murphy EA, Singh S, Sukhu AC, Wolfe I, Adurty S, et al. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Obstet Gynecol. 2022;139(3):373–80. doi: 10.1097/AOG.0000000000004693